Last reviewed · How we verify
Coagulation assay — Competitive Intelligence Brief
phase 2
Diagnostics / Hematology
Biologic
Live · refreshed every 30 min
Target snapshot
Coagulation assay (Coagulation assay) — Assistance Publique - Hôpitaux de Paris. A coagulation assay is a diagnostic test that measures blood clotting function and identifies coagulation disorders.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Coagulation assay TARGET | Coagulation assay | Assistance Publique - Hôpitaux de Paris | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Coagulation assay CI watch — RSS
- Coagulation assay CI watch — Atom
- Coagulation assay CI watch — JSON
- Coagulation assay alone — RSS
Cite this brief
Drug Landscape (2026). Coagulation assay — Competitive Intelligence Brief. https://druglandscape.com/ci/coagulation-assay. Accessed 2026-05-13.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab